Placental pathological findings in coronavirus disease 2019: Perinatal outcomes

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Citação
PLACENTA, v.128, p.23-28, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Placental alterations caused by severe acute respiratory coronavirus-2 (SARS-CoV-2) infection have already been described, but most studies used small sample groups and the difference according to the severity of the disease has not been verified. Our objective was to describe placental alterations in patients with coronavirus disease 2019 (COVID-19) and analyze the association of pathological placental findings with the clinical pa-rameters of COVID-19 and perinatal results.Methods: This was a nested study within a prospective cohort study involving 109 symptomatic pregnant women with COVID-19. The prevalence of observed placental alterations was described, and the associations of path-ological findings with the clinical parameters of COVID-19 severity and with perinatal outcomes were assessed.Results: The frequency of types of placental features was poor maternal vascular perfusion in 45% of cases, poor fetal vascular perfusion in 33.9%, hematogenous origin infection in 32.1%, and morphological changes corre-sponding to ascending infection in 21.1%. Hematogenous infection differed significantly according to COVID-19 severity (p = 0.008), with a prevalence ratio (PR) of 1.74 (95% confidence interval, 1.02-2.98) in the moderate COVID-19 group compared to the mild COVID-19 group. Among the perinatal outcomes, there was an unex-pected inverse association between prematurity and placental infection of hematogenous origin, with lower rates of prematurity among cases with inflammation of hematogenous origin (p = 0.029).Discussion: Moderate SARS-Cov-2 infection presented a higher prevalence of placental pathological findings. There was no association of placental findings with adverse perinatal outcomes.
Palavras-chave
Placenta, COVID-19, Perinatal mortality, Infectious pregnancy complications
Referências
  1. ALTSHULER G, 1984, ARCH PATHOL LAB MED, V108, P71
  2. Baergen RN, 2020, PEDIATR DEVEL PATHOL, V23, P177, DOI 10.1177/1093526620925569
  3. Santana LB, 2021, J OBSTET GYNAECOL RE, V47, P2131, DOI 10.1111/jog.14784
  4. Brito S.B.P., 2020, J BRAS PATOL MED LAB, V56, P1, DOI [10.5935/1676-2444.20200056, DOI 10.5935/1676-2444.20200056]
  5. Buckley T, 2021, CUREUS, V13, DOI 10.7759/cureus.12522
  6. Cribiu FM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145427
  7. Debelenko L, 2021, HUM PATHOL, V109, P69, DOI 10.1016/j.humpath.2020.12.004
  8. Di Toro F, 2021, CLIN MICROBIOL INFEC, V27, P36, DOI 10.1016/j.cmi.2020.10.007
  9. Gomez UT, 2022, CLINICS, V77, DOI 10.1016/j.clinsp.2022.100073
  10. Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
  11. Gulersen M, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100211
  12. He M, 2022, FETAL PEDIATR PATHOL, V41, P403, DOI 10.1080/15513815.2020.1828517
  13. Hecht JL, 2020, MODERN PATHOL, V33, P2092, DOI 10.1038/s41379-020-0639-4
  14. Hosier H., 2020, MEDRXIV, DOI [10.1101/2020.04.30.20083907, DOI 10.1101/2020.04.30.20083907]
  15. Jamieson DJ, 2022, AM J OBSTET GYNECOL, V226, P177, DOI 10.1016/j.ajog.2021.08.054
  16. Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
  17. Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
  18. Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040
  19. Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107
  20. Kotlar B, 2021, REPROD HEALTH, V18, DOI 10.1186/s12978-021-01070-6
  21. Kreis NN, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081777
  22. Levitan D, 2021, ARCH PATHOL LAB MED, V145, P648, DOI 10.5858/arpa.2020-0793-SA
  23. Ministerio da Saude, 2021, MANUAL RECOMENDACOES
  24. Narang K, 2020, MAYO CLIN PROC, V95, P1750, DOI 10.1016/j.mayocp.2020.05.011
  25. Ochani RohanKumar, 2021, Infez Med, V29, P20
  26. Patberg ET, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.10.020
  27. Prabhu M, 2020, BJOG-INT J OBSTET GY, V127, P1548, DOI 10.1111/1471-0528.16403
  28. Prochaska E, 2020, AM J REPROD IMMUNOL, V84, DOI 10.1111/aji.13306
  29. Resta L, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050723
  30. Roberts D.J., 2021, ATLAS PLACENT PATHOL, Vfirst, P528
  31. Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089
  32. Smithgall MC, 2020, HISTOPATHOLOGY, V77, P994, DOI 10.1111/his.14215
  33. Taglauer E, 2020, PLACENTA, V100, P69, DOI 10.1016/j.placenta.2020.08.015
  34. Tasca C, 2021, PLACENTA, V110, P9, DOI 10.1016/j.placenta.2021.04.002
  35. Wastnedge EAN, 2021, PHYSIOL REV, V101, P303, DOI 10.1152/physrev.00024.2020
  36. Wong YP, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010094
  37. Zhang PL, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100197